Get every episode summarized
Each time Big Take publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements in weight loss treatments–and the fight over who should pay for them. And Dr. Angela Fitch, a physician and president of the Obesity Medical Association, talks about the challenges of treating obesity.
Read their reporting here: Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK
Have questions or comments for Wes and the team? Reach us at [email protected].
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Big Take publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Big Take
Japan Hikes Rates, Reshaping Carry Trade
Big Take
Most Americans Say They’re Working Class. Are They?
Big Take
Why the Federal Reserve Raised Interest Rates
Big Take
Can the AI Industry Slow Down?
Big Take